Prevalence and antimicrobial resistance of diarrheagenic Escherichia coli and Shigella species associated with acute diarrhea in Tehran, Iran.
A study was performed to determine the prevalence and antimicrobial resistance of Shigella species and diarrheagenic Escherichia coli isolates cultured from patients with acute diarrhea in Tehran, Iran. Between May 2003 and May 2005, 1120 diarrheal specimens were collected and assayed for bacterial enteropathogens by conventional and molecular methods. Etiological agents were isolated from 564 (50.3%) specimens, and included 305 (54%) E coli, 157 (27.8%) Shigella species, and 102 (18%) from other genera of bacteria. The predominant E coli was Shiga toxin-producing E coli (105 isolates [34.5%]) and the predominant Shigella serotype was Shigella sonnei (88 isolates [56.1%]). A high rate of antibiotic resistance was observed among E coli, with 40 of 53 (75.5%) Shiga toxin-producing E coli isolates resistant to amoxicillin and tetra-cycline, and eight (5.2%) E coli isolates resistant to more than six antibiotics. Most Shigella isolates were resistant to tetracycline (95%) and trimethoprim-sulfamethoxazole (91.7%), with greatest antibiotic resistance observed among S sonnei (53 of 88 [60.2%] isolates). Antibiotic resistance is widespread in diarrheagenic E coli and Shigella in children with acute diarrhea in Tehran, Iran; hence, updated strategies for appropriate use of antimicrobial agents in Iran are needed.
Jafari
Fereshteh
F
Department of Foodborne and Diarrheal Diseases, Research Center for Gastroenterology and Liver Diseases (RCGLD), Shaheed Beheshti University, M.C., Tehran, Iran;
Hamidian
Mohammad
M
Rezadehbashi
Maryam
M
Doyle
Michael
M
Salmanzadeh-Ahrabi
Siavosh
S
Derakhshan
Faramarz
F
Reza Zali
Mohammad
M
Clin Infect Dis. 1998 Feb;26(2):341-5
9502453
Clin Microbiol Infect. 2004 Sep;10(9):804-10
15355411
Mikrobiyol Bul. 2007 Jul;41(3):453-7
17933258
Mol Microbiol. 1989 Dec;3(12):1729-34
2695745
Ann Trop Paediatr. 2004 Mar;24(1):45-51
15005966
Microb Drug Resist. 2002 Summer;8(2):123-8
12118516
J Pediatr Gastroenterol Nutr. 2000 Mar;30(3):241-5
10749405
Rev Infect Dis. 1991 Mar-Apr;13 Suppl 4:S342-6
2047660
Tanzan Health Res Bull. 2007 Sep;9(3):186-9
18087897
Jpn J Infect Dis. 2008 Jul;61(4):269-73
18653967
J Chemother. 1998 Aug;10(4):285-90
9720466
Can J Infect Dis. 2000 Jul;11(4):181-6
18159288
Antimicrob Agents Chemother. 2005 Feb;49(2):816-9
15673777
J Clin Microbiol. 2000 Dec;38(12):4425-9
11101575
J Health Popul Nutr. 2003 Jun;21(2):96-102
13677436
J Clin Microbiol. 2007 Oct;45(10):3352-9
17715376
Ann Trop Paediatr. 2005 Mar;25(1):35-9
15814047
Antimicrob Agents Chemother. 1999 Dec;43(12):3022-4
10582903
Emerg Infect Dis. 2002 Feb;8(2):175-80
11897070
Public Health. 1997 Jan;111(1):5-10
9033217
East Mediterr Health J. 2007 Mar-Apr;13(2):287-93
17684850
Indian J Med Res. 2006 Feb;123(2):145-50
16575113
East Mediterr Health J. 2007 Mar-Apr;13(2):243-9
17684844
J Clin Microbiol. 1999 Oct;37(10):3113-7
10488163
Saudi Med J. 2008 Mar;29(3):388-92
18327365
J Postgrad Med. 1995 Oct-Dec;41(4):104-6
10707731
Antimicrob Agents Chemother. 2002 Dec;46(12):3739-43
12435670